Literature DB >> 12500035

Hormone replacement therapy in epidemiologic studies and randomized clinical trials - are we checkmate?

Karin B Michels1.   

Abstract

Mesh:

Year:  2003        PMID: 12500035     DOI: 10.1097/00001648-200301000-00003

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


× No keyword cloud information.
  5 in total

1.  Post menopausal hormones and measures of subclinical atherosclerosis: the multi-ethnic study of atherosclerosis.

Authors:  Eyal Shahar; Gregory L Burke; Mary Cushman; Susan R Heckbert; Pamela Ouyang; Moyses Szklo
Journal:  Prev Med       Date:  2007-12-27       Impact factor: 4.018

2.  Point-counterpoint. The triumph of the null hypothesis: epidemiology in an age of change.

Authors:  Wasim Maziak
Journal:  Int J Epidemiol       Date:  2008-12-17       Impact factor: 7.196

3.  Menopausal hormone therapy and sleep-disordered breathing: evidence for a healthy user bias.

Authors:  Anna G Mirer; Paul E Peppard; Mari Palta; Ruth M Benca; Amanda Rasmuson; Terry Young
Journal:  Ann Epidemiol       Date:  2015-08-06       Impact factor: 3.797

4.  New evidence rekindles the hormone therapy debate.

Authors:  Noreen Goldman
Journal:  J Fam Plann Reprod Health Care       Date:  2010-04

5.  Socioeconomic position and hormone replacement therapy use: explaining the discrepancy in evidence from observational and randomized controlled trials.

Authors:  Debbie A Lawlor; George Davey Smith; Shah Ebrahim
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.